Synthesis of chalcone derivatives on steroidal framework and their anticancer activities. 2007

Hari Om Saxena, and Uzma Faridi, and J K Kumar, and Suaib Luqman, and M P Darokar, and Karuna Shanker, and Chandan S Chanotiya, and M M Gupta, and Arvind S Negi
Central Institute of Medicinal and Aromatic Plants (CIMAP), P.O. CIMAP, Kukrail Picnic Spot Road, Lucknow, U.P., India.

Chalcone derivatives on estradiol framework have been synthesized. Some of the derivatives showed potent anticancer activity against some human cancer cell lines. Compounds 9 and 19 showed potent activity against MCF-7, a hormone dependent breast cancer cell line. Chalcone 7 was further modified to the corresponding indanone derivative (19) using the Nazarov reaction, which showed better activity than the parent compound against the MCF-7 breast cancer cell line. Active anticancer derivatives were also evaluated for osmotic hemolysis using the erythrocyte as a model system. It was observed that chalcone derivatives showing cytotoxicity against cancer cell lines did not affect the fragility of erythrocytes and hence may be considered as non-toxic to normal cells.

UI MeSH Term Description Entries
D002599 Chalcone An aromatic KETONE that forms the core molecule of CHALCONES. Benzalacetophenone,Benzylideneacetophenone,1,3-Diphenyl-2-Propen-1-One,Chalkone,1,3 Diphenyl 2 Propen 1 One
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Hari Om Saxena, and Uzma Faridi, and J K Kumar, and Suaib Luqman, and M P Darokar, and Karuna Shanker, and Chandan S Chanotiya, and M M Gupta, and Arvind S Negi
September 1978, Die Pharmazie,
Hari Om Saxena, and Uzma Faridi, and J K Kumar, and Suaib Luqman, and M P Darokar, and Karuna Shanker, and Chandan S Chanotiya, and M M Gupta, and Arvind S Negi
May 2006, Bioorganic & medicinal chemistry,
Hari Om Saxena, and Uzma Faridi, and J K Kumar, and Suaib Luqman, and M P Darokar, and Karuna Shanker, and Chandan S Chanotiya, and M M Gupta, and Arvind S Negi
November 2017, Molecules (Basel, Switzerland),
Hari Om Saxena, and Uzma Faridi, and J K Kumar, and Suaib Luqman, and M P Darokar, and Karuna Shanker, and Chandan S Chanotiya, and M M Gupta, and Arvind S Negi
February 2018, Archives of physiology and biochemistry,
Hari Om Saxena, and Uzma Faridi, and J K Kumar, and Suaib Luqman, and M P Darokar, and Karuna Shanker, and Chandan S Chanotiya, and M M Gupta, and Arvind S Negi
January 2011, Anti-cancer drugs,
Hari Om Saxena, and Uzma Faridi, and J K Kumar, and Suaib Luqman, and M P Darokar, and Karuna Shanker, and Chandan S Chanotiya, and M M Gupta, and Arvind S Negi
March 2002, Bioorganic & medicinal chemistry,
Hari Om Saxena, and Uzma Faridi, and J K Kumar, and Suaib Luqman, and M P Darokar, and Karuna Shanker, and Chandan S Chanotiya, and M M Gupta, and Arvind S Negi
October 2019, Bioorganic chemistry,
Hari Om Saxena, and Uzma Faridi, and J K Kumar, and Suaib Luqman, and M P Darokar, and Karuna Shanker, and Chandan S Chanotiya, and M M Gupta, and Arvind S Negi
February 2017, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
Hari Om Saxena, and Uzma Faridi, and J K Kumar, and Suaib Luqman, and M P Darokar, and Karuna Shanker, and Chandan S Chanotiya, and M M Gupta, and Arvind S Negi
January 2017, Iranian journal of pharmaceutical research : IJPR,
Hari Om Saxena, and Uzma Faridi, and J K Kumar, and Suaib Luqman, and M P Darokar, and Karuna Shanker, and Chandan S Chanotiya, and M M Gupta, and Arvind S Negi
August 2014, Molecules (Basel, Switzerland),
Copied contents to your clipboard!